Pyrimidine deoxyribonucleoside triphosphate metabolic process

pathway activity — cross-omics
GO:0009211Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Pyrimidine deoxyribonucleoside triphosphate metabolic process pathway is significantly associated with the protein abundance of multiple proteins, with the LUAD cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are RRM2, SMC4, and MCM2, each associated with the pathway in up to 9 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Pyrimidine deoxyribonucleoside triphosphate metabolic process activity versus RRM2 in LUAD (Pearson r = 0.34).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUADRRM2 →+0.773+0.059<.001<.00139
GBMSMC4 →+0.640+0.071.001<.00139
LUADMCM2 →+0.682+0.057<.001<.00139
LUADMCM3 →+0.707+0.057<.001<.00139
LUADMCM4 →+0.729+0.058<.001<.00139
LUADMCM5 →+0.689+0.058<.001<.00139
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0009211 vs RRM2 — LUAD

Per-sample scatter of Pyrimidine deoxyribonucleoside triphosphate metabolic process activity vs RRM2 in LUAD.

Explore this scatter interactively →

Exploration